Comment · Thu, February 13, 2014
MDA with a SSRI
Original post in this thread
wolpertinger777 · 12 points
I'm a huge fan of MDA for its psychedelic properties. It has a really special "outrospection" that I have yet to experience in other substances.
The only problem for me is its supposed neurotoxicity because of monoamine release. Would using an SSRI (such as kanna) remove the serotonin releasing properties of the drug and therefore curb the issue of neurotoxicity?
I know that the compound might feel a little different without the serotonin release and the psychedelia might require higher dosages but would it still be effective?
TO SUM UP: Would using an SSRI (such as kanna) with MDA block the serotonin releasing properties and thereby create a non-neurotoxic dopamine/norepinephrine releasing agent with 5ht2a agonism?
What they were answering
Herperderperton · 1 points
This seems unlikely to me because standard psychs bind 5-HT2A and 5-HT2C as agonists, but are not reported to release norepinephrine or dopamine, nor do they elicit standard stimulant type behaviours in humans or in rats (hyperlocomotion). MDMA, however, does elicit hyperlocomotion in mice.
u/MisterYouAreSoDumb
http://www.ncbi.nlm.nih.gov/pubmed/16001122
These results support and extend our previous findings by showing that 5-HT2A and 5-HT2C/B receptors differentially regulate the expression of MDMA-induced behavioral and striatal neuronal responses, either directly or through the modulation of DA transmission.
The results from this study offer corroborative support to the hypothesis that MDMA-associated hyperactivity might be in part mediated through inactivation of 5-HT2C receptors with the consequent increase in DA transmission.
So it seems that activation of the 5-HT2A receptors, paired with inactivation of the 5-HT2C receptors, mediates the release of DA and NE. Perhaps MDMA antagonizes the 5-HT2C receptor, while at the same time elevating 5-HT levels, causing the binding of 5-HT to 5-HT2A receptors, which instigates a cascading release of DA and NE.